From the product classification, regenerative medicine can be divided into three parts: regenerative materials, stem cell repair and regenerative organs. Regenerated materials can be used for bone repair, oral repair, medical beauty and so on. Stem cell repair, based on stem cell technology, repairs non-renewable tissues and organs; Regeneration of organs, based on stem cells, biological 3D printing and other technologies, the development of artificial tissues and organs, including artificial blood vessels, artificial kidneys, artificial pancreas and so on. At present, regenerative medicine enterprises in China are mostly concentrated in the fields of regenerative materials and stem cell repair, while regenerative organs are regarded as the "pyramid tip" of artificial organs, and few enterprises arrange regenerative organs.
Comparison of product production and sales of representative enterprises in regenerative medicine industry
At present, several listed companies in China's regenerative medicine industry realize their income by developing, producing and selling regenerative medical devices, and most of them are implantable medical devices, but there are differences in the diseases to which the products are applicable. For example, the active biological bone products of Zhenghai Bio are used for orthopedic diseases, and the artificial biological heart valve products of Bairen Medical are used for heart diseases. Judging from the production and sales of products of various enterprises, in 2022, due to the influence of macro-economy and centralized procurement of medical industry, the production and sales rates of Zhenghai Bio, Maipu Medical and Bairen Medical products were all below 100%, resulting in a certain inventory; The production and marketing rate of biological products in Guan Hao reached 265,438+00.02%. In fact, the sales volume decreased compared with the previous year, mainly because of the large inventory in the previous year, and the company reduced its product output in 2022.
Analysis of Import and Export Trade of Regenerative Medicine Industry
Import trade is increasing.
China's regenerative medicine industry is in the early stage of development, and its products lack competitiveness. High-end products still need to be imported from the United States, Germany, the Netherlands and other countries. From the perspective of import trade, from 20 17 to 2022, the import trade of China's regenerative medicine industry showed an overall growth trend, and the total import volume increased from 349.55 tons in 20 17 to 460.56 tons in 2022. In 2020, due to the COVID-19 epidemic, the total import volume decreased. The total import volume is consistent with the change of import volume. In 2022, the total import of regenerative medicine industry in China was 5.54 billion yuan. From June to March, 2023, the total import volume of China's regenerative medicine industry was 120.20 tons, and the total import volume was 14 1 billion yuan.
Note: The product tariff number of the import and export trade data query is: 902 13900 (including artificial heart valves, other artificial body parts and other medical devices), the same below.
-export trade is relatively stable.
On the export side, the export trade of China's regenerative medicine industry is mainly carried out in developing countries such as Indian, Egyptian and Pakistani. From 2065438+07 to 2022, the export trade of China's regenerative medicine industry changed steadily, and the export volume fluctuated around 250-300 tons. In 2022, the total export volume of China's regenerative medicine industry was 290.74 tons, and the total export volume was 292 million yuan. From June 5438 to March 2023, the total export volume was 75 12 tons, and the total export volume was 87 million yuan.
-The average import price of products is much higher than the average export price.
Based on the above analysis, it can be found that the total import and export trade volume of regenerative medicine industry in China is quite different. From the average product price, the average import price of China's regenerative medical products in 20 18-2023 is above 10000 yuan /kg, which is much higher than the average export price of 1000 yuan. For example, in 2022, the average import price of regenerative medical products in China was1.028 yuan/kg, and the average export price was 1.004 yuan/kg, which was more than ten times the average export price. Mainly because China mainly imports high-end regenerative medical devices from the United States, Germany and other technologically developed countries, and the product value is high; And exports are mainly low-end products with low export value of developing countries.
For more research and analysis of this industry, please refer to the analysis report of Foresight Industry Research Institute "Development Prospect Forecast and Investment Strategic Planning of Biomedical Industry in China".